Genetic Screening Helps Identify Immunotherapy Treatment Options
Most types of prostate cancers don’t respond well to immunotherapy. However, genetic screening efforts can help identify which immunotherapy treatment…
Most types of prostate cancers don’t respond well to immunotherapy. However, genetic screening efforts can help identify which immunotherapy treatment…
New findings indicate that, when it comes to younger men suffering from high-grade prostate cancers, survival rates are higher when these cancers are…
Emergent research has discovered evidence that androgen deprivation therapy (ADT), a common hormone therapy for patients diagnosed with prostate cancer…
A newly-developed drug compound that takes a different approach to fighting prostate cancer has shown some very promising results in early testing phases…
A new research study has found that some men may fear the side effects from prostate cancer treatments, even though these life saving treatments may…
A pioneering type of high-dose, short cycle radiation treatments, one that provides only a small number of those doses to its patients, has shown to be…
More evidence has emerged that hormone therapy treatment for those diagnosed with prostate cancer increases cardiovascular risks for patients.
At least one new study has revealed the relationship between aggressive chemotherapy prostate cancer treatments and the likelihood that the patient will…
A recent research study has shown that a new immunotherapy drug has proven effective in reducing prostate-specific antigen levels in a specific subset…
A team of scientists from Purdue University has banded together to put the brakes on aggressive prostate cancer by reducing its lethality through new…